Multiple Biopharma Companies Including BeiGene, Livzon Monoclonal Antibody, Bio-Thera, FedLab, GreenCross Bio, and TNM Biosciences Confirm Participation in Merck’s Exclusive Closed-Door Salon

Jul 30, 2025 12:30 CST Updated 12:30

Hengrui Pharmaceutical

Chemical Drug Manufacturer

Previous Recommendation 1

Merck and Hengrui Pharmaceutical Reach Strategic Cooperation on Next-Generation Selective PARP1 Inhibitor and Antibody-Drug Conjugate to Further Enrich Oncology Pipeline

Previous Recommendation 2

Merck Group Announces Renewed Collaboration with Hengrui Pharmaceutical to Advance Commercialization of Oral GnRH Antagonist in Assisted Reproductive Field

Click "Read Original" to register immediately